Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease

Am J Geriatr Psychiatry. 2006 Jul;14(7):561-72. doi: 10.1097/01.JGP.0000221334.65330.55.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Aged
  • Alkaloids
  • Alzheimer Disease / complications*
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / therapy*
  • Brain / pathology
  • Caregivers / education
  • Cholinesterase Inhibitors / therapeutic use
  • Cognition Disorders / diagnosis
  • Cognition Disorders / etiology*
  • Dementia / diagnosis
  • Dementia / etiology
  • Dementia / therapy
  • Diagnostic and Statistical Manual of Mental Disorders
  • Galantamine / therapeutic use
  • Geriatric Psychiatry / methods
  • Geriatric Psychiatry / standards*
  • Health Services for the Aged / standards*
  • Humans
  • Phenylcarbamates / therapeutic use
  • Professional-Family Relations
  • Rivastigmine
  • Sesquiterpenes / therapeutic use
  • Tacrine / therapeutic use
  • United States

Substances

  • Alkaloids
  • Cholinesterase Inhibitors
  • Phenylcarbamates
  • Sesquiterpenes
  • huperzine A
  • Galantamine
  • Tacrine
  • Rivastigmine